Sionna Therapeutics, Inc. (SION)
3.43
-0.27
(-7.30%)
USD |
NASDAQ |
Nov 12, 16:00
3.41
-0.02
(-0.58%)
After-Hours: 20:00
Sionna Therapeutics Shareholders Equity (Quarterly) : 240.52M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 240.52M |
| June 30, 2026 | 265.78M |
| March 31, 2026 | 288.21M |
| December 31, 2025 | 306.83M |
| September 30, 2025 | 321.67M |
| June 30, 2025 | 336.43M |
| Date | Value |
|---|---|
| March 31, 2025 | 351.77M |
| December 31, 2024 | 166.66M |
| September 30, 2024 | 181.82M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 34.16M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 20.91B |
| Capricor Therapeutics, Inc. | 209.76M |
| ARS Pharmaceuticals, Inc. | -11.96M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Immunic, Inc. | 127.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 263.26M |
| Total Liabilities (Quarterly) | 22.74M |
| Debt to Equity Ratio | 0.0322 |
| Current Ratio | 13.92 |
| Net Debt Paydown Yield | 0.12% |